We then assessed the in vivo efficacy of trifunctional CD123-NKCE in a xenogeneic disseminated AML tumor model induced by the intravenous (i.v.)injection of MOLM-13 tumor cells. The gene discussed is IL3RA; the disease is acute myeloid leukemia.